Company Filing History:
4 out of 512 
1 out of 559 
Years Active: 2012-2025
Title: Innovations of Inventor Kai Deng
Introduction
Kai Deng is a notable inventor based in Guilderland, NY (US), recognized for his contributions to the field of immunology. He holds a total of five patents, showcasing his innovative approach to developing new adjuvants for vaccines.
Latest Patents
One of his latest patents focuses on triterpene saponins, methods of synthesis, and their uses. This invention relates to triterpene glycoside saponin-derived adjuvants, including the synthesis and intermediates involved. Notably, QS-7, a potent immuno-adjuvant developed by Deng, is significantly less toxic than QS-21, a related saponin currently favored in anticancer and antiviral vaccines. The tedious isolation and purification protocols have previously hindered the clinical development of QS-7. However, Deng's novel semi-synthetic method utilizes a hydrolyzed prosapogenin mixture to synthesize QS-7, QS-21, and related analogs, greatly facilitating access to these compounds for preclinical and clinical evaluation.
Career Highlights
Throughout his career, Kai Deng has worked with prestigious institutions such as the Sloan Kettering Institute for Cancer Research and the Memorial Sloan Kettering Cancer Center. His work has significantly impacted the development of new therapeutic strategies in cancer treatment.
Collaborations
Deng has collaborated with
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.